# Combining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 Diabetes

> **NCT02315495** · PHASE3 · COMPLETED · sponsor: **Zilin Sun** · enrollment: 22 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Saxagliptin
- **DRUG:** Acarbose

## Key facts

- **NCT ID:** NCT02315495
- **Lead sponsor:** Zilin Sun
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-03
- **Primary completion:** 2016-08-26
- **Final completion:** 2016-08-26
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2018-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02315495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02315495, "Combining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02315495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*